Medications for Infantile Spasms

8 results

Acthar (repository corticotropin)

(Repository Corticotropin)
Mallinckrodt ARD LLC
Usage: Acthar Gel is indicated for treating infantile spasms in children under 2, acute exacerbations of multiple sclerosis in adults, and as adjunctive therapy for various rheumatic disorders, collagen diseases, severe dermatologic and allergic conditions, certain ophthalmic diseases, symptomatic sarcoidosis, and to manage nephrotic syndrome.
Lundbeck Pharmaceuticals LLC
Usage: SABRIL is indicated for adjunctive therapy in adults and children (2 years and older) with refractory complex partial seizures who have not responded to other treatments. It is also indicated as monotherapy for pediatric patients (1 month to 2 years) with infantile spasms, with careful consideration of potential vision loss risks.
Lundbeck Pharmaceuticals LLC
Usage: SABRIL is indicated as adjunctive therapy for adults and children (2 years and older) with refractory complex partial seizures and as monotherapy for infants (1 month to 2 years) with infantile spasms, where benefits outweigh the risk of vision loss. Not a first-line treatment for complex partial seizures.
Zydus Lifesciences Limited
Usage: Vigabatrin for oral solution is indicated as adjunctive therapy for refractory complex partial seizures in adults and children (2 years and older) not responding to other treatments, and as monotherapy for infantile spasms in children (1 month to 2 years). Vision loss risks must be considered.
Cipla USA, Inc.
Usage: Vigabatrin for oral solution is indicated as adjunctive therapy for refractory complex partial seizures in patients 2 years and older, and as monotherapy for infantile spasms in children 1 month to 2 years old, where benefits outweigh the risks of vision loss.
Lupin Pharmaceuticals Inc
Usage: Vigabatrin for oral solution is indicated as adjunctive therapy for refractory complex partial seizures in patients aged 2 and older, and as monotherapy for infantile spasms in children aged 1 month to 2 years, when the benefits outweigh the risk of vision loss.
Zydus Pharmaceuticals (USA) Inc.
Usage: Vigabatrin is indicated as adjunctive therapy for adults and children (2 years and older) with refractory complex partial seizures, and as monotherapy for pediatric patients (1 month to 2 years) with infantile spasms. Vision loss risks must be considered against potential benefits. Not a first-line treatment for CPS.
Novadoz Pharmaceuticals LLC
Usage: Vigabatrin for oral solution is indicated as adjunctive therapy for adults and pediatric patients (2 years and older) with refractory complex partial seizures and as monotherapy for infants (1 month to 2 years) with infantile spasms, when potential benefits outweigh the risk of vision loss.